EDGAR Filing Documents for 0001129928-24-000031

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001129928-24-000031

Filing Date

2024-05-08

Accepted

2024-05-08 13:43:00

Documents

Period of Report

2024-05-08

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	form6k2024rbcconf.htm	6-K	18193
2	EX-99.1	oncy2024rbcconf.htm	EX-99.1	10869
	Complete submission text file	0001129928-24-000031.txt		30057

Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5

Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380

ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 24925199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)